📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Third-Generation Antibody Drug Conjugates for Cancer Therapy-A Balancing Act (2016)

First Author: Vankemmelbeke M

Attributed to: Improving the functional affinity of human anti-glycan monoclonal antibodies (mabs) for cancer therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4155/tde-2016-0002

PubMed Identifier: 26893243

Publication URI: http://europepmc.org/abstract/MED/26893243

Type: Journal Article/Review

Parent Publication: Therapeutic Delivery

Issue: 3

ISSN: 2041-5990